Citation Tools

Original research
Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T

Download to a citation manager

Cite this article as:
Dorff T, Hirasawa Y, Acoba J, et al
Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T